MedPath

大连泠美制药有限公司

Ownership
-
Established
2016-02-19
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

19

NMPA:19

Drug Approvals

Norfloxacin Capsules

Product Name
诺氟沙星胶囊
Approval Number
国药准字H21021176
Approval Date
Jul 2, 2021
NMPA

蟾酥镇痛膏

Approval Number
国药准字Z21020935
Approval Date
Jul 2, 2021
NMPA

Saponated Cresol Solution

Product Name
甲酚皂溶液
Approval Number
国药准字H21024403
Approval Date
Jul 2, 2021
NMPA

麝香壮骨膏

Approval Number
国药准字Z21020936
Approval Date
Jul 2, 2021
NMPA

Hydrogen Peroxide Solution

Product Name
过氧化氢溶液
Approval Number
国药准字H21024402
Approval Date
Jul 2, 2021
NMPA

辣椒风湿膏

Approval Number
国药准字Z21020931
Approval Date
Jul 2, 2021
NMPA

Paracetamol Tablets

Product Name
对乙酰氨基酚片
Approval Number
国药准字H21021173
Approval Date
Jul 2, 2021
NMPA

Sterile Elastic Strip

Product Name
消毒弹性创可贴
Approval Number
国药准字H21022999
Approval Date
Jul 2, 2021
NMPA

Iodine Tincture

Product Name
碘酊
Approval Number
国药准字H21021172
Approval Date
Jul 2, 2021
NMPA

Furancilin Styptic Plaster

Product Name
呋喃西林止血膏布
Approval Number
国药准字H21023000
Approval Date
Jul 2, 2021
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.